Review highlights gut permeability's impact on neuroinflammation in Parkinson's disease, suggesting microbiota-targeted therapies.
Key Points
Increased gut permeability allows toxins and misfolded proteins to enter the bloodstream, worsening neuroinflammation and Parkinson's disease pathology.
Research emphasizes the role of neuroinflammation in neurodegeneration, linking gut health and the central nervous system closely.
Innovative therapeutic strategies aim to restore gut integrity through personalized microbiome engineering and modulation of gut bacteria.
Therapeutic focus on enhancing short-chain fatty acids production may reduce inflammation and slow down neurodegeneration in Parkinson's disease.